Roche Holding Management
Management criteria checks 3/4
Roche Holding's CEO is Thomas Schinecker, appointed in Mar 2023, has a tenure of 1.08 years. total yearly compensation is CHF5.34M, comprised of 23.4% salary and 76.6% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth CHF624.69K. The average tenure of the management team and the board of directors is 4.5 years and 7.1 years respectively.
Key information
Thomas Schinecker
Chief executive officer
CHF5.3m
Total compensation
CEO salary percentage | 23.4% |
CEO tenure | 1.1yrs |
CEO ownership | 0.0003% |
Management average tenure | 4.5yrs |
Board average tenure | 7.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CHF11b |
Sep 30 2023 | n/a | n/a | CHF11b |
Jun 30 2023 | n/a | n/a | CHF11b |
Mar 31 2023 | n/a | n/a | CHF12b |
Dec 31 2022 | CHF5m | CHF1m | CHF12b |
Sep 30 2022 | n/a | n/a | CHF14b |
Jun 30 2022 | n/a | n/a | CHF15b |
Mar 31 2022 | n/a | n/a | CHF14b |
Dec 31 2021 | CHF4m | CHF1m | CHF14b |
Sep 30 2021 | n/a | n/a | CHF14b |
Jun 30 2021 | n/a | n/a | CHF14b |
Mar 31 2021 | n/a | n/a | CHF14b |
Dec 31 2020 | CHF4m | CHF879k | CHF14b |
Sep 30 2020 | n/a | n/a | CHF14b |
Jun 30 2020 | n/a | n/a | CHF13b |
Mar 31 2020 | n/a | n/a | CHF13b |
Dec 31 2019 | CHF2m | CHF609k | CHF13b |
Compensation vs Market: Thomas's total compensation ($USD5.86M) is about average for companies of similar size in the UK market ($USD5.62M).
Compensation vs Earnings: Thomas's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Thomas Schinecker (48 yo)
1.1yrs
Tenure
CHF5,335,592
Compensation
Dr. Thomas Schinecker serves as Chairman of the Board at Genentech, Inc. since March 2023. He serves as Chief Executive Officer at Roche Holding AG since March 15, 2023. He has been Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 11.1yrs | CHF11.48m | 0.039% CHF 68.9m | |
Chief Executive Officer | 1.1yrs | CHF5.34m | 0.00035% CHF 624.7k | |
Chief Financial & Information Officer | 13yrs | CHF6.05m | 0.0059% CHF 10.6m | |
Head of Investor Relations | no data | no data | no data | |
General Counsel | 4yrs | no data | no data | |
Chief Compliance Officer | 4.3yrs | no data | no data | |
Head of Group Communications | 4.5yrs | no data | no data | |
Chief People Officer | 8.1yrs | CHF4.25m | 0.0018% CHF 3.3m | |
Head of Group Media Relations | no data | no data | no data | |
Head of Group Business Development and M&A | no data | no data | no data | |
Global Head of Pharma Partnering | 5.7yrs | no data | no data | |
Head of Neuroscience Clinical Development | no data | no data | no data |
4.5yrs
Average Tenure
56yo
Average Age
Experienced Management: 0QQ6's management team is considered experienced (4.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 11.1yrs | CHF11.48m | 0.039% CHF 68.9m | |
Non-Executive Independent Director | 9.3yrs | CHF330.00k | 0.00013% CHF 232.0k | |
Director | 1.1yrs | no data | no data | |
Independent Vice Chairman | 28.3yrs | CHF402.82k | 3.53% CHF 6.3b | |
Independent Non Executive Director | 4.1yrs | CHF360.00k | 0.00025% CHF 446.2k | |
Non-Executive Independent Director | 9.3yrs | CHF346.71k | 0% CHF 0 | |
Non-Executive Independent Director | 7.1yrs | CHF336.16k | 0.00040% CHF 713.9k | |
Non-Executive Independent Director | 4.1yrs | CHF364.59k | no data | |
Director | 1.1yrs | no data | no data | |
Non-Executive Independent Director | 8.1yrs | CHF367.02k | 0.00034% CHF 606.8k | |
Independent Non-Executive Director | 2.1yrs | CHF272.50k | no data |
7.1yrs
Average Tenure
56yo
Average Age
Experienced Board: 0QQ6's board of directors are considered experienced (7.1 years average tenure).